EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Targeting fibroblast TNF receptor 1 attenuates type 17 skin inflammation

Kellen J Cavagnero, Fengwu Li, Carlos Aguilera, Haley Jo, Marta Palomo-Irigoyen, Andrea Roso Mares, Hung Chan, Richard L Gallo

Cell Reports · 2025-08 · 44 (8) · 116111

DOI: 10.1016/j.celrep.2025.116111 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Reports, 2025-08. Verfasst von Kellen J Cavagnero und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, University of California, San Diego, La Jolla, CA 92093, USA. Hauptthemen laut MEDLINE: Fibroblasts, Receptors, Tumor Necrosis Factor, Type I, Skin, Inflammation. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institutes of Health, Hartwell Foundation, University of California San Diego.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FibroblastsReceptors, Tumor Necrosis Factor, Type ISkinInflammationAnimalsHumansMiceTumor Necrosis Factor-alphaInterleukin-17PsoriasisImiquimodSignal TransductionMice, Inbred C57BLNeutrophilsKeratinocytesMice, Knockout

Stichwörter der Autor:innen

CP: ImmunologyIL-17TNFanti-TNFchemokinesfibroblastsinflammationneutrophilspsoriasisskintranscriptomics

Substanzen

Receptors, Tumor Necrosis Factor, Type ITumor Necrosis Factor-alphaInterleukin-17Imiquimod

Autor:innen und Institutionen

  • Department of Dermatology, University of California, San Diego, La Jolla, CA 92093, USA.
  • Department of Dermatology, University of California, San Diego, La Jolla, CA 92093, USA. Electronic address: rgallo@health.ucsd.edu.

Förderung

  • National Institutes of Health
  • Hartwell Foundation
  • University of California San Diego

Zitieren

APA

Cavagnero, K. J., Li, F., Aguilera, C., Jo, H., Palomo-Irigoyen, M., Mares, A. R., Chan, H., & Gallo, R. L. (2025). Targeting fibroblast TNF receptor 1 attenuates type 17 skin inflammation. Cell Reports, 44(8), 116111. https://doi.org/10.1016/j.celrep.2025.116111

Vancouver

Cavagnero KJ, Li F, Aguilera C, Jo H, Palomo-Irigoyen M, Mares AR, et al. Targeting fibroblast TNF receptor 1 attenuates type 17 skin inflammation. Cell Reports. 2025;44(8):116111. doi:10.1016/j.celrep.2025.116111

BibTeX
@article{Cavagnero2025,
  author = {Cavagnero, Kellen J and Li, Fengwu and Aguilera, Carlos and Jo, Haley and Palomo-Irigoyen, Marta and Mares, Andrea Roso and Chan, Hung and Gallo, Richard L},
  title = {Targeting fibroblast TNF receptor 1 attenuates type 17 skin inflammation},
  journal = {Cell Reports},
  year = {2025},
  volume = {44},
  number = {8},
  pages = {116111},
  doi = {10.1016/j.celrep.2025.116111}
}
Kostenlos starten →